• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of immunosuppressive mechanisms in sepsis using single-cell sequencing and development of novel therapeutic strategies

Research Project

Project/Area Number 21K09017
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 55060:Emergency medicine-related
Research InstitutionOsaka University

Principal Investigator

Ito Hiroshi  大阪大学, 大学院医学系研究科, 特任助教(常勤) (80836594)

Co-Investigator(Kenkyū-buntansha) 清水 健太郎  大阪大学, 医学部附属病院, 助教 (60379203)
小倉 裕司  大阪大学, 大学院医学系研究科, 招へい教授 (70301265)
松本 寿健  大阪大学, 医学部附属病院, 特任助教(常勤) (70644003)
Project Period (FY) 2021-04-01 – 2025-03-31
Project Status Completed (Fiscal Year 2024)
Budget Amount *help
¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Fiscal Year 2023: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2022: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2021: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Keywords敗血症 / CyTOF / 免疫抑制 / RNA解析 / シングルセルRNA解析 / PD-1
Outline of Research at the Start

敗血症に対してこれまで数多くの抗炎症、 侵襲制御を目的とした治療が試みられてきたが、依然として根本的な治療には至っていない。本研究では、敗血症患者における血液を用いてトランスクプリトームを行い、敗血症急性期のリンパ球における免疫抑制を分子病態学的な観点から解明し、新たな免疫抑制の治療開発につなげる。

Outline of Final Research Achievements

In sepsis, excessive inflammation (SIRS) and immune suppression (CARS) occur simultaneously. The increase in secondary infections and mortality during the subacute phase after sepsis is thought to be due to the prolonged immune suppression. In this study, we aimed to identify key genes that influence the pathophysiology of immune suppression. We evaluated the changes in surface markers of CD4+ T cells in sepsis patients and their progression after ICU admission. The proportion of PD1+CXCR3+Tbet+ Tfh1 cells decreased, while the proportion of Ki67+PD1+ Tfh1 cells increased. Even among PD-1+ CD4+ T cells, different characteristics were observed. Heat maps revealed differences in gene expression between cell populations.

Academic Significance and Societal Importance of the Research Achievements

敗血症になった後に免疫が抑制される病態の一つが明らかとなった。これにより免疫の賦活化に関与する研究の更なる礎にもなる。そして敗血症のみならず他の重症疾患においても同様の研究が可能であることが予想され、疾患ごとに重要と思われる免疫疲労に関する細胞集団、そして遺伝子発現など更なる病態解明につながることが期待される。

Report

(5 results)
  • 2024 Annual Research Report   Final Research Report ( PDF )
  • 2023 Research-status Report
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (3 results)

All 2024 2023

All Journal Article (2 results) Presentation (1 results)

  • [Journal Article] Atypical and non-classical CD45RBlo memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-192024

    • Author(s)
      Priest David G.、Ebihara Takeshi、Tulyeu Janyerkye、Sondergaard Jonas N.、Sakakibara Shuhei、Sugihara Fuminori、Nakao Shunichiro、Togami Yuki、Yoshimura Jumpei、Ito Hiroshi、Onishi Shinya、Muratsu Arisa、Mitsuyama Yumi、Ogura Hiroshi、Oda Jun、Okusaki Daisuke、Matsumoto Hisatake、Wing James B.
    • Journal Title

      Nature Communications

      Volume: 15 Issue: 1 Pages: 1-21

    • DOI

      10.1038/s41467-024-50997-4

    • Related Report
      2024 Annual Research Report
  • [Journal Article] Relationship between extravascular leakage and clinical outcome on computed tomography of isolated traumatic brain injury2024

    • Author(s)
      Ito Hiroshi、Nakamura Youhei、Togami Yuki、Onishi Shinya、Nakao Shunichiro、Ogura Hiroshi、Oda Jun
    • Journal Title

      Acute Medicine & Surgery

      Volume: 11 Issue: 1 Pages: 1-8

    • DOI

      10.1002/ams2.931

    • Related Report
      2024 Annual Research Report
  • [Presentation] RNA 解析を用いた COVID-19 による ARDS の病態解明2023

    • Author(s)
      伊藤 弘
    • Organizer
      集中治療医学会
    • Related Report
      2023 Research-status Report

URL: 

Published: 2021-04-28   Modified: 2026-01-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi